Formulation, solubilization, purification, and refolding of tissue factor pathway inhibitor

A method of modifying protein solubility employs polyionic polymers. These facilitate the solubilization, formulation, purification and refolding of proteins especially incorrectly folded proteins and aggregated proteins. Compositions are described that are suitable for formulating TFPI. The composi...

Full description

Saved in:
Bibliographic Details
Main Authors Dorin, Glenn J, Arve, Bo H, Pattison, Gregory L, Halenbeck, Robert F, Johnson, Kirk, Chen, Bao-Lu, Bana, Rejsharan K, Hoba, Maninder S, Madani, Hassan, Tsang, Michael, Gustafson, Mark E, Bild, Gary S, Johnson, Gary V
Format Patent
LanguageEnglish
Published 04.04.2006
Online AccessGet full text

Cover

Loading…
More Information
Summary:A method of modifying protein solubility employs polyionic polymers. These facilitate the solubilization, formulation, purification and refolding of proteins especially incorrectly folded proteins and aggregated proteins. Compositions are described that are suitable for formulating TFPI. The compositions allow preparation of pharmaceutically acceptable compositions of TFPI at concentrations above 0.2 mg/mL and above 10 mg/mL.